195 related articles for article (PubMed ID: 8230492)
1. Mouse mammary tumor virus-induced tumorigenesis in sag transgenic mice: a laboratory model of natural selection.
Golovkina TV; Prescott JA; Ross SR
J Virol; 1993 Dec; 67(12):7690-4. PubMed ID: 8230492
[TBL] [Abstract][Full Text] [Related]
2. B and T cells are required for mouse mammary tumor virus spread within the mammary gland.
Golovkina TV; Dudley JP; Ross SR
J Immunol; 1998 Sep; 161(5):2375-82. PubMed ID: 9725233
[TBL] [Abstract][Full Text] [Related]
3. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus.
Wrona T; Dudley JP
J Virol; 1996 Feb; 70(2):1246-9. PubMed ID: 8551589
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mouse mammary tumor virus superantigen expression prevents viral infection.
Golovkina TV; Chervonsky A; Dudley JP; Ross SR
Cell; 1992 May; 69(4):637-45. PubMed ID: 1316806
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of exogenous and endogenous mouse mammary tumor virus RNA in vivo results in viral recombination and broadens the virus host range.
Golovkina TV; Jaffe AB; Ross SR
J Virol; 1994 Aug; 68(8):5019-26. PubMed ID: 8035502
[TBL] [Abstract][Full Text] [Related]
7. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
[TBL] [Abstract][Full Text] [Related]
8. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
9. BALB/Mtv-null mice responding to strong mouse mammary tumor virus superantigens restrict mammary tumorigenesis.
Bhadra S; Lozano MM; Dudley JP
J Virol; 2009 Jan; 83(1):484-8. PubMed ID: 18922863
[TBL] [Abstract][Full Text] [Related]
10. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of resistance to mouse mammary tumor virus infection.
Golovkina TV
J Virol; 2000 Mar; 74(6):2752-9. PubMed ID: 10684291
[TBL] [Abstract][Full Text] [Related]
12. Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression.
Xu L; Wrona TJ; Dudley JP
Virology; 1996 Jan; 215(2):113-23. PubMed ID: 8560758
[TBL] [Abstract][Full Text] [Related]
13. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
14. Initial stages of mammary tumor virus infection are superantigen independent.
Pobezinskaya Y; Chervonsky AV; Golovkina TV
J Immunol; 2004 May; 172(9):5582-7. PubMed ID: 15100301
[TBL] [Abstract][Full Text] [Related]
15. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Schirrmacher V; Beutner U; Bucur M; Umansky V; Rocha M; von Hoegen P
J Immunol; 1998 Jul; 161(2):563-70. PubMed ID: 9670928
[TBL] [Abstract][Full Text] [Related]
16. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
17. Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection.
Golovkina TV; Dudley JP; Jaffe AB; Ross SR
Proc Natl Acad Sci U S A; 1995 May; 92(11):4828-32. PubMed ID: 7761408
[TBL] [Abstract][Full Text] [Related]
18. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
19. Expression of a MHC class II transgene determines both superantigenicity and susceptibility to mammary tumor virus infection.
Pucillo C; Cepeda R; Hodes RJ
J Exp Med; 1993 Oct; 178(4):1441-5. PubMed ID: 8397273
[TBL] [Abstract][Full Text] [Related]
20. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
